Figure 3.
Aldh3a2 is dispensable for normal hematopoiesis. (A) Aldh3a2 knockdown with Aldh3a2-sh-1 shows no difference in the number of N-GMPs in methylcellulose compared with N-GMPs infected with control shRNA (n = 3 wells per group). (B) Aldh3a2−/− mice (KO) show one half of total aldehyde dehydrogenase enzyme activity in whole BM compared with Aldh3a2+/+ mice (WT). (C-E) BM analysis showing frequency of Lin−cKit+Sca1+CD48−CD150+ hematopoietic stem cells (HSCs) (C), committed myeloid progenitors (common myeloid progenitors [CMPs], granulocyte-monocyte progenitors [GMPs], and megakaryocyte-erythrocyte progenitors [MEPs]) (D), and B cells (B220+) and myeloid cells (Mac1+) (E) in Aldh3a2-WT and Aldh3a2-KO mice. (F-G) Relative peripheral blood reconstitution (F) and contribution to B cells (B220+), myeloid cells (Mac1+), and T cells (CD3+) (G) 20 weeks after transplantation of recipient B6.SJL (CD45.1) mice transfused with whole BM cells from Aldh3a2-WT or KO mice (CD45.2+) competed with equal numbers of WT CD45.1 whole BM cells (n = 10 recipients per group). Data are representative of ≥2 independent experiments; n = 3 mice per genotype per experiment. Data are represented as mean ± standard deviation. P > .05 was considered nonsignificant (ns). ***P < .001.

Aldh3a2 is dispensable for normal hematopoiesis. (A) Aldh3a2 knockdown with Aldh3a2-sh-1 shows no difference in the number of N-GMPs in methylcellulose compared with N-GMPs infected with control shRNA (n = 3 wells per group). (B) Aldh3a2−/− mice (KO) show one half of total aldehyde dehydrogenase enzyme activity in whole BM compared with Aldh3a2+/+ mice (WT). (C-E) BM analysis showing frequency of LincKit+Sca1+CD48CD150+ hematopoietic stem cells (HSCs) (C), committed myeloid progenitors (common myeloid progenitors [CMPs], granulocyte-monocyte progenitors [GMPs], and megakaryocyte-erythrocyte progenitors [MEPs]) (D), and B cells (B220+) and myeloid cells (Mac1+) (E) in Aldh3a2-WT and Aldh3a2-KO mice. (F-G) Relative peripheral blood reconstitution (F) and contribution to B cells (B220+), myeloid cells (Mac1+), and T cells (CD3+) (G) 20 weeks after transplantation of recipient B6.SJL (CD45.1) mice transfused with whole BM cells from Aldh3a2-WT or KO mice (CD45.2+) competed with equal numbers of WT CD45.1 whole BM cells (n = 10 recipients per group). Data are representative of ≥2 independent experiments; n = 3 mice per genotype per experiment. Data are represented as mean ± standard deviation. P > .05 was considered nonsignificant (ns). ***P < .001.

Close Modal

or Create an Account

Close Modal
Close Modal